Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATLANTIS: Apixaban vs Standard of Care after TAVI
NCT02664649Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2016
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of apixaban in aortic stenosis (AS), sponsored by Assistance publique - Hôpitaux de Paris. Started Aug 2016; status: completed.
02
Drugs
apixaban
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on NCT02664649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02664649.